Bioceres Crop Solutions, known for developing drought-tolerant wheat and soybeans, has reported a substantial loss of US$189.9 million for the second quarter of the 2026 fiscal year, which ended on December 31, 2025. The company’s CEO, Federico Trucco, addressed shareholders regarding the reasons behind this financial setback, attributing it largely to a conflict with a U.S. creditor, Jasper, linked to the acquisition of ProFarm, a company formerly known as Marrone Bio Innovations. This creditor is involved in an ongoing legal dispute, which has complicated Bioceres' financial landscape and led to the decision to discontinue some of its assets, including ProFarm.

Jasper's involvement, with a claim amounting to approximately US$110 million, has posed significant challenges for Bioceres. The financial strain from this conflict not only reflects on their balance sheets but also signals potential instability within the company. The legal battle continues, and its outcome could have long-lasting implications for Bioceres’ operational strategy and its future investments.

Trucco's statements emphasize that the company is actively assessing its options moving forward, which includes the potential divestment of assets to stabilize their financial situation. This situation raises concerns about the company's ability to sustain its innovative projects and maintain its competitive edge in the agricultural biotechnology sector, especially as it continues to expand its portfolio and navigate complex market conditions.